Integrated analysis of N-glycosylation and Alzheimer’s disease: identifying key biomarkers and mechanisms
MAX, MLEC, and TMEM59 represent key N-glycosylation-linked diagnostic biomarkers for AD. This integrative framework provides novel insights into AD pathogenesis and lays the foundation for personalized diagnostic tools and therapies, warranting experimental validation.
Authors
- S. C. Yuan
- Wei-Ting Lu (ORCID: https://orcid.org/0000-0002-1405-4806)
- S.-W Ding (ORCID: https://orcid.org/0000-0001-8069-1056)
- Haogang Zhu (ORCID: https://orcid.org/0000-0003-1771-2752)
- Bo Cai (ORCID: https://orcid.org/0000-0002-4487-6202)
- Wenjun Chen (ORCID: https://orcid.org/0000-0002-2645-337X)
- Junsheng Sun (ORCID: https://orcid.org/0009-0002-3593-122X)
- H. -R. Bao (ORCID: https://orcid.org/0000-0001-5706-2155)
Institutions
- Wuxi No.2 People's Hospital (CN)
- Wuxi Taihu Hospital (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3389/fnagi.2025.1597511
- Citations
- 1
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Yangzhou University